Inhibition of 11β-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis

Hepatology

Volumn 30, Issue 3, 1999, Pages 623-629

  Ackermann, Daniel ^a   Vogt, Bruno ^a   Escher, Geneviève ^a   Dick, Bernhard ^a   Reichen, Jurg ^a   Frey, Brigitte M ^a   Frey, Felix J ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; BILE ACID; CHENODEOXYCHOLIC ACID; CORTICOSTERONE; CORTICOSTERONE DERIVATIVE; DEHYDROCORTICOSTERONE; GLUCOCORTICOID; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; POTASSIUM; SODIUM; HYDROXYSTEROID DEHYDROGENASE; NITRIC OXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; GAS CHROMATOGRAPHY; KIDNEY COLLECTING TUBULE; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; EXPERIMENTAL LIVER CIRRHOSIS; GENETICS; LIGATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; URINE;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; CHENODEOXYCHOLIC ACID; CORTICOSTERONE; HYDROXYSTEROID DEHYDROGENASES; KIDNEY TUBULES, COLLECTING; LIGATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0032588886     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300303     Document Type: Article

References (28)

1. Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. N Engl J Med 1988;319:1127-1138.
2. Martin PY, Ginès P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998;339:533-541.
3. Levy M, Wexler MJ. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity. J Lab Clin Med 1978;91:520-536.
4. Levy M, Allotey JB. Temporal relationships betwen urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis. J Lab Clin Med 1978;92:560-569.
5. Wensing G, Sabra R, Branch RA. The onset of sodium retention in experimental cirrhosis in rats is related to a critical threshold of liver function. HEPATOLOGY 1990;11:779-786.
6. Frey FJ. Kinetics and dynamics of prednisolone. Endocr Rev 1987;8:453-473.
7. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988;243:583-585.
8. Edwards CRW, Stewart PM, Burt D, Brett L, McIntyre MA, Sutano WS, de Kloet ER, et al. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 1988;2:986-989.
9. Escher G, Frey FJ, Frey BM. 11β-hydroxysteroid dehydrogenase accounts for low prednisolone/prednisone ratios in the kidney. Endocrinology 1994;135:101-106.
10. Agarwal AK, Monder C, Eckstein B, White PC. Cloning and expression of rat cDNA encoding corticosteroid 11β-hydroxysteroid dehydrogenase. J Biol Chem 1989;264:18939-18943.
11. Albitson AL, Obeyesekere VR, Smith RE, Krozowski Z. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 1994;105:R11-R17.
12. White PC, Tomoatsu M, Agarwal AK. 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 1997;18:135-156.
13. Escher G, Vogt B, Beck T, Guntern D, Frey BM, Frey FJ. Reduced 11β-hydroxysteroid dehydrogenase activity in the remaining kidney following nephrectomy. Endocrinology 1998;139:1533-1539.
14. Hirasawa G, Sasano H, Takahashi K, Fukushima K, Suzuki T, Hiwatashi N, Toyota T, et al. Colocalization of 11β-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia. J Clin Endocr 1997;82:3859-3863.
15. Naray-Fejes-Toth A, Fejes-Toth G. Extranuclear localization of endogenous 11β-hydroxysteroid dehydrogenase-2 in aldosterone target cells. Endocrinology 1998;139:2955-2959.
16. Ferrari P, Obeyesekere VR, Li K, Wilson RC, Mew MI, Funder JW, Krozowski ZS. Point mutations abolish 11β-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess. Mol Cell Endocrinol 1996;119:21-24.
17. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11beta;-hydroxysteroid dehydrogenase. Nat Genet 1995;10:394-399.
18. Escher G, Navrocki A, Staub T, Vishwanath BS, Frey BM, Reichen J, Frey FJ. Down-regulation of hepatic and renal 11β-hydroxysteroid dehydrogenase in rats with liver cirrhosis. Gastroenterology 1998;114:175-184.
19. 2 activity in rats. J Clin Invest 1996;98:365-371.
20. Gross JB, Reichen J, Zeltner T, Zimmermann A. The evolution of changes in quantitative liver function tests in a rat model of cirrhosis: correlation with morphometric measurement of hepatocyte mass. HEPATOLOGY 1987;7:457-463.
21. Fuster D, Escher G, Vogt B, Ackermann D, Dick B, Frey BM, Frey FJ. Furosemide inhibits 11β-hydroxysteroid dehydrogenase type 2. Endocrinology 1998;139:3849-3854.
22. Alfaidy N, Blot-Chabaud M, Robic D, Kenouch S, Bourbouze R, Bonvalet JP, Farman N. Characteristics and regulation of 11β-hydroxysteroid dehydrogenase of proximal and distal nephron. Biochim Biophys Acta 1995;1243:461-468.
23. Doucet A, Katz AI, Morel F Determination of Na-K-ATPase activity in single segments of the mammalian nephron. Am J Physiol 1979;237:F105-F113.
24. Phillips HJ. Dye exclusion tests for cell viability. In: Kruse Jr PF, Patterson Jr MK, eds. Tissue Culture: Methods and Applications. London: Academic Press, 1973:406-408.
25. Monder C, Lakshmi V, Miroff Y. Kinetic studies on rat liver 11βhydroxysteroid dehydrogenase. Biochim Biophys Acta 1991;1115:23-29.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
27. Agarwal AK, Monder C, Eckstein B, White PC. Cloning and expression of rat cDNA encoding corticosteroid 11β-hydroxysteroid dehydrogenase. J Biol Chem 1989;264:18939-18943.
28. 2 activity in rats. J Clin Invest 1993;92:1974-1980.